4107 results for «66+video+🫣🫣🫣🫣🫣🫣🫣»
4107 results
Focal or diffuse coronary disease: how can PPG measurement contribute to clinical decision-making?
22 May 2025 – From EuroPCR 2025
How can physiology guide treatment decisions beyond ischemia detection? In this round-table recorded at EuroPCR 2025, Thomas Engstrøm, Carlos Collet and Jeroen Sonck examine how pullback pressure gradient (PPG) makes it possible to identify the distribution pattern of coronary artery disease—focal or diffuse—based on a continuous...
One year outcomes of transfemoral J-valve for chronic aortic regurgitation, a prospective multicenter study in 127 cases
20 May 2025 – From EuroPCR 2025
In this #europcr 2025 roundtable, Lai Wei and Dongming Hou present the latest data on the transfemoral J-Valve for chronic aortic regurgitation.
They begin with the China-DVD study, highlighting that aortic regurgitation is now slightly more prevalent than aortic stenosis in China. The conversation then shifts to...
Latest clinical evidence on intravascular lithotripsy from EuroPCR 2025
20 May 2025 – From EuroPCR 2025
In this #europcr 2025 roundtable, Niels Thue Olsen and Margaret McEntegart discuss with Flavio Luciano Ribichini the latest data on intravascular lithotripsy (IVL), based on two pivotal studies.
- EMPOWER CAD: the first prospective, real-world PCI trial dedicated to women with complex, calcified coronary artery disease. With an IVL-first strategy...
Are we undertreating aortic regurgitation?
20 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Victoria Delgado, Helge Möllmann, and Dan Blackman gather to discuss a crucial but often under-addressed challenge in structural heart disease: the under-referral and under-treatment of patients with aortic regurgitation (AR).
The conversation begins with the diagnostic challenges surrounding severe AR, followed by a striking observation—only...
Coronary Interventions: EuroPCR 2025 highlights
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Rasha Al-Lamee, Nieves Gonzalo, and Thomas Cuisset highlighted key advances in coronary interventions, with a strong emphasis on managing complex cases—particularly calcified lesions.
Throughout the Course, LIVE cases and expert hotlines showcased dedicated devices and evolving strategies designed specifically for these challenging lesions. Advanced...
What are the essential aspects of transcatheter LAA closure?
20 May 2025 – From EuroPCR 2025
Ole De Backer and Philippe Garot discuss the rapid evolution of transcatheter left atrial appendage (LAA) occlusion.
They begin by contrasting patient selection in Europe and the US, where approaches diverge significantly: in Europe, very high bleeding risk remains the main criterion, while in the US, LAA...
Structural and Valvular Interventions: EuroPCR 2025 highlights
22 May 2025 – From EuroPCR 2025
Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...
How to tailor transcatheter mitral therapies in 2025? A new era
20 May 2025 – From EuroPCR 2025
In this discussion from EuroPCR 2025, Mayra Guerrero, Thomas Modine, and Philipp Lurz explore the evolving landscape of mitral valve treatment.
While transcatheter edge-to-edge repair (TEER) remains a safe and effective approach, it doesn't suit every patient. Alternatives like transcatheter mitral valve replacement (TMVR), annuloplasty, and NeoChord implantation...
Repair and replace: latest insights in transcatheter treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
Join Michael Mullen, Federico De Marco, and Philipp Lurz as they discuss the latest breakthroughs in the treatment of mitral and tricuspid regurgitation at EuroPCR 2025. In this roundtable session, they delve into both repair and replacement techniques, offering insights into new systems and their impact...
Preventing distal particles embolization after DCB angioplasty
21 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Aloke Finn and Antonio Colombo share their insights on a specific and often overlooked complication of drug-coated balloon (DCB) angioplasty: particulate embolization.
They begin by clarifying the distinction between this phenomenon and traditional distal embolization, explaining that particulate embolization is iatrogenic and device-related—it is...
Advances in the development of drug-coated balloon
22 May 2025 – From EuroPCR 2025
Join Florim Cuculi and Rony Mathew at this EuroPCR 2025 roundtable to assess the evolution of drug-coated balloons (DCBs) and their role in daily practice.
DCBs offer a compelling alternative to stent implantation in selected cases. However, they are not interchangeable—each is built using different drugs, carriers,...
Early treatment of severe aortic stenosis: do we need to wait?
20 May 2025 – From EuroPCR 2025
Rahul Sharma and Darren Walters share their perspectives on shifting treatment strategies for aortic stenosis (AS), with a focus on early intervention.
Their conversation draws on the EARLY TAVR trial, which compared transcatheter aortic valve replacement (TAVR) to clinical surveillance in patients with severe, asymptomatic AS at low surgical...
Complications: coronary stent loss
14 Dec 2018
Embolised device complications
Stent loss and embolisation although infrequent (<1% of PCI) since factory crimping was introduced has not been eliminated entirely. Retrieval techniques are technically challenging and evidence for their success is limited to case reports and case series from experienced operators. The key principle for retrieval...
How to treat emergency coronary perforation
17 Oct 2019
Complications
Perforations can be life threating complications, but if recognised quickly and managed correctly can have a positive outcome. This section explains how to treat a coronary perforation.
In total there are 5 types.
PCR Complication Team: Patrick Calvert, Eric Eeckhout, Michael Haude, Amir Lerman, Olivier Muller
Types of coronary perforationThere are five types...
A journey with Charles Dotter: his contribution to transluminal angioplasty
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...
The new rotational atherectomy system for treating undilatable coronary lesions
22 Apr 2018
Watch the video on demand with A. De Belder, B. Farah and S. Doshi!
TAVI and Coronary access
11 Dec 2019
Watch the video on demand with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre
PCR e-Course 2020 - Check out the virtual Exhibition
Best of #EuroPCR 2023 – Day 3 of the World-Leading Course!
REFLECT II: A randomized trial of a cerebral embolic protection device during TAVR
16 Oct 2020
At TCT Connect 2020, Jeffrey Moses presented the results of the REFLECT II trial. Mirvat Alasnag provides a summary of the key messages.
Author
